Wall Street investors closely monitoring trade discussions between the US and China drove stocks higher as Commerce Secretary ...

Wall Street investors closely monitoring trade discussions between the US and China drove stocks higher as Commerce Secretary ...

While pharmaceutical executives raise valid concerns about the lack of detailed implementation plans for the “Most Favored ...

WASHINGTON — Trump administration officials are expected to release more details on their plan to lower prescription drug ...

(Reuters) -Talks with the Trump administration about lowering U.S. drug prices have so far not provided clarity on when and ...

Republican presidential candidate Donald Trump has proposed a “Most Favored Nation” pricing plan to lower the cost of ...

Novo Nordisk's Q1 showed robust sales/EPS growth, fueled by soaring GLP-1 demand in a multi-billion dollar market. Read why I ...

In JAMA, the FDA's Makary and Prasad said they will focus on modernizing review processes and lowering drug costs but don't outright mention precision medicine.

As President Donald Trump vows to bridge the drug pricing gap between the U.S. and other developed countries with his “most ...

These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing ...